Investor Kinnevik AB (publ)
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kinnevik AB (publ) . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-11-04 13G/A RXRX / Recursion Pharmaceuticals, Inc. 10,405,668 11,905,668
2023-05-22 13G RXRX / Recursion Pharmaceuticals, Inc. 10,405,668
2022-11-14 13D BBLN / Babylon Holdings Limited - Class A 54,942,568 115,433,522
2022-05-25 13G/A BBLN / Babylon Holdings Limited - Class A 54,942,568
2021-04-15 13D/A TDOC / Teladoc Health, Inc. 7,491,124 7,491,124
2020-12-21 13D/A TDOC / Teladoc Health, Inc. 7,491,124 7,491,124
2020-11-09 13D TDOC / Teladoc Health, Inc. 7,491,124
2020-11-03 13D/A US5391831030 / Livongo Health, Inc. 12,653,927 0
2020-01-21 13G/A TIGO / Millicom International Cellular S.A. 37,835,438 0
2019-07-31 13D US5391831030 / Livongo Health, Inc. 12,653,927
2019-02-01 13G TIGO / Millicom International Cellular S.A. 37,835,438